Search research articles
Contact Us
Filters
Showing results (271-280 of 298) with videos related to
Page
of 30
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 2, 2022
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy
Sara E Looby, Amy Kantor, Tricia H Burdo, et al.
Annals of Internal Medicine
|
April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
The Lancet. HIV
|
May 11, 2023
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Lameck Chinula, Lauren Ziemba, Sean Brummel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2025
Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIV
Steven K Grinspoon, Maya Watanabe, Heather J Ribaudo, et al.
JACC. Cardiovascular Imaging
|
December 1, 2025
Statin Effects on Pericoronary Adipose Tissue Density in People With HIV: Insights From the REPRIEVE Trial
Borek Foldyna, Ibrahim Hadzic, Thomas Mayrhofer, et al.
AIDS (London, England)
|
November 11, 2025
Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial
Marissa R Diggs, Sarah M Chu, Kathleen V Fitch, et al.
Contemporary Clinical Trials
|
August 9, 2021
Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platform
Anne Friedland, Adrian F Hernandez, Kevin J Anstrom, et al.
Open Forum Infectious Diseases
|
September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy
Rinki Deo, Manish C Choudhary, Owen T Glover, et al.
JACC. Advances
|
June 28, 2024
Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk Populations
Julia Karady, Michael T Lu, Göran Bergström, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Page
of 30
Search research articles
Search
Showing results (271-280 of 298) with videos related to
Sort By:
Page
of 30
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 2, 2022
Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy
Sara E Looby, Amy Kantor, Tricia H Burdo, et al.
Annals of Internal Medicine
|
April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
The Lancet. HIV
|
May 11, 2023
Efficacy and safety of three antiretroviral therapy regimens started in pregnancy up to 50 weeks post partum: a multicentre, open-label, randomised, controlled, phase 3 trial
Lameck Chinula, Lauren Ziemba, Sean Brummel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 26, 2025
Factors Affecting Risk of CVD Events in a Global CVD Prevention Cohort of People with HIV
Steven K Grinspoon, Maya Watanabe, Heather J Ribaudo, et al.
JACC. Cardiovascular Imaging
|
December 1, 2025
Statin Effects on Pericoronary Adipose Tissue Density in People With HIV: Insights From the REPRIEVE Trial
Borek Foldyna, Ibrahim Hadzic, Thomas Mayrhofer, et al.
AIDS (London, England)
|
November 11, 2025
Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial
Marissa R Diggs, Sarah M Chu, Kathleen V Fitch, et al.
Contemporary Clinical Trials
|
August 9, 2021
Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platform
Anne Friedland, Adrian F Hernandez, Kevin J Anstrom, et al.
Open Forum Infectious Diseases
|
September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy
Rinki Deo, Manish C Choudhary, Owen T Glover, et al.
JACC. Advances
|
June 28, 2024
Coronary Plaque in People With HIV vs Non-HIV Asymptomatic Community and Symptomatic Higher-Risk Populations
Julia Karady, Michael T Lu, Göran Bergström, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Page
of 30